EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Stroke‐Homing Peptide‐ DNase1 Alleviates Intestinal Ischemia Reperfusion Injury by Selectively Degrading Neutrophil Extracellular Traps

Tingting Liu, Xinrong Lv, Qingshan Xu, Xiuting Qi, Shenghui Qiu, Yaqi Luan, Na Shen, Jing Cheng, Lan Jin, Tian Tian, Wentao Liu, Lai Jin and 1 more

Cell Proliferation · 2025

DOI: 10.1111/cpr.70010 ↗

At a glance

Journal article in Cell Proliferation, 2025. Written by Tingting Liu and 12 co-authors. Institution: Graduate College of Dalian Medical University, Dalian, Liaoning, China. Major MEDLINE topics: Extracellular Traps, Reperfusion Injury, Deoxyribonuclease I, Intestines. Cited 6 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Neutrophil extracellular traps (NETs) act as a vital first line of defence against tissue damage and pathogens, playing a significant role in improving diseases such as intestinal ischemia reperfusion injury (IRI). However, we observed that after intestinal injury, intestinal bacteria and lipopolysaccharides (LPS) can enter the circulatory system, leading to a significant secondary increase in NETs production and the subsequent activation of a coagulation cascade. This phenomenon contributes to a pathological process known as the ‘second strike’ of NETs, which exaggerates intestinal damage and microcirculation disturbance. Selectively mitigating the detrimental effects associated with this second strike presents a promising therapeutic strategy. We developed an innovative conjugate of stroke‐homing peptide (SHp) and DNase1 (SHp‐DNase1) to enhance the stability of DNase in the bloodstream while selectively targeting NETs in thromboembolic events. The effects of SHp‐DNase1 on blood flow, ischemia, and vascular leakage were evaluated in a mouse model using laser Doppler flowmetry and an in vivo imaging system. Levels of LPS and NETs were elevated in patients with IRI. Similarly, the expression of NETs and LPS was upregulated in mice with intestinal IRI. In vivo imaging revealed disturbances in intestinal microcirculation, accompanied by intestinal leakage, which were effectively reversed by the administration of SHp‐DNase1. Almost all of the SHp‐DNase1 localised to the gastrointestinal tract, demonstrating the effective targeting of DNase1 to the site of intestinal injury via SHp guidance. Furthermore, the combination of SHp‐DNase1 and CRO significantly reduced the expression of ischemia‐inducible factors, leading to a marked decrease in mortality in the mouse model. These findings suggest that intestinal LPS leakage correlated with NETs exacerbation plays a critical role in IRI. The combination of SHp‐DNase1 and CRO is an effective treatment strategy by simultaneously controlling inflammation and addressing microcirculatory disorders induced by NETs in the therapy of IRI.

Subjects

MeSH terms (MEDLINE)

Extracellular TrapsReperfusion InjuryDeoxyribonuclease IIntestinesNeutrophilsPeptidesAnimalsMiceLipopolysaccharidesMaleHumansMice, Inbred C57BLDisease Models, Animal

Author keywords

ceftriaxone sodiumintestinal ischemia reperfusion injurymicrocirculatory disturbanceneutrophil extracellular trapsstroke‐homing peptide–DNase1

Substances

Deoxyribonuclease ILipopolysaccharidesPeptides

Authors and institutions

  • Graduate College of Dalian Medical University, Dalian, Liaoning, China.
  • Department of Interventional and Vascular Surgery, The Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital), Jiangsu, China.
  • Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China.
  • School of Basic Medical Science, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Department of Gastroenterology, Shanghai General Hospital of Nanjing Medical University, Shanghai, China.

Funding

  • National Natural Science Foundation of China

Cite

APA

Liu, T., Lv, X., Xu, Q., Qi, X., Qiu, S., Luan, Y., Shen, N., Cheng, J., Jin, L., Tian, T., Liu, W., Jin, L., & Jia, Z. (2025). Stroke‐Homing Peptide‐ DNase1 Alleviates Intestinal Ischemia Reperfusion Injury by Selectively Degrading Neutrophil Extracellular Traps. Cell Proliferation. https://doi.org/10.1111/cpr.70010

Vancouver

Liu T, Lv X, Xu Q, Qi X, Qiu S, Luan Y, et al. Stroke‐Homing Peptide‐ DNase1 Alleviates Intestinal Ischemia Reperfusion Injury by Selectively Degrading Neutrophil Extracellular Traps. Cell Proliferation. 2025. doi:10.1111/cpr.70010

BibTeX
@article{Liu2025,
  author = {Liu, Tingting and Lv, Xinrong and Xu, Qingshan and Qi, Xiuting and Qiu, Shenghui and Luan, Yaqi and Shen, Na and Cheng, Jing and Jin, Lan and Tian, Tian and Liu, Wentao and Jin, Lai and Jia, Zhongzhi},
  title = {Stroke‐Homing Peptide‐ DNase1 Alleviates Intestinal Ischemia Reperfusion Injury by Selectively Degrading Neutrophil Extracellular Traps},
  journal = {Cell Proliferation},
  year = {2025},
  doi = {10.1111/cpr.70010}
}
Start for free →